Aurinia Pharmaceuticals
AUPH
AUPH
64 hedge funds and large institutions have $145M invested in Aurinia Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
21% less call options, than puts
Call options by funds: $2.41M | Put options by funds: $3.04M
27% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 11
Holders
64
Holding in Top 10
–
Calls
$2.41M
Puts
$3.04M
Top Buyers
| 1 | +$1.4M | |
| 2 | +$985K | |
| 3 | +$904K | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$747K |
| 5 |
Franklin Resources
San Mateo,
California
|
+$699K |
Top Sellers
| 1 | -$1.06M | |
| 2 | -$943K | |
| 3 | -$604K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$536K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$312K |